Researchers sought to determine whether chemotherapeutic conditioning for allogeneic HSCT would lead to low rates of complications and mortality in young children with ALL.
News
Researchers sought to determine whether treatment of relapsed/refractory CLL or SLL with venetoclax plus obinutuzumab would lead to durable responses.
Researchers sought to determine whether maternal occupational exposure to anticancer medications can be linked pediatric leukemia.
Researchers sought to determine whether adding gemtuzumab ozogamicin to FLAG-Ida would improve rates of relapse in patients with newly-diagnosed AML.
A retrospective study sought to identify factors that correspond with occurrence of acute kidney injury in patients with hematologic cancer after high-dose methotrexate without drug monitoring.
Obe-cel is an investigational autologous CAR T-cell therapy designed with a fast off-rate CD19 binder to reduce toxicity and increase long-term persistence.
Researchers sought to determine whether adding sorafenib to chemotherapy would improve survival in patients with FLT3-ITD AML.
Study finds increased risk for cancer overall and for specific cancers for first- and second-degree relatives.
Researchers sought to determine whether combination therapy with venetoclax and an anti-CD20 monoclonal antibody would improve outcomes in patients with CLL.
Researchers sought to determine whether midostaurin in combination with intensive chemotherapy would be effective in adult patients with FLT3-mutated AML.